TY - JOUR
T1 - The implementation of a nationwide anomaly screening programme improves prenatal detection of major cardiac defects
T2 - an 11-year national population-based cohort study
AU - Hautala, J.
AU - Gissler, M.
AU - Ritvanen, A.
AU - Tekay, A.
AU - Pitkänen-Argillander, O.
AU - Stefanovic, V.
AU - Sarkola, T.
AU - Helle, E.
AU - Pihkala, J.
AU - Pätilä, T.
AU - Mattila, I. P.
AU - Jokinen, E.
AU - Räsänen, J.
AU - Ojala, T.
N1 - Funding Information:
This research was supported by the Finnish Cultural Foundation, the Foundation for Paediatric Research, and the Kirsti and Tor Johansson's Heart and Cancer Foundation as working grants for the corresponding author. The content is solely the responsibility of the authors and the funders were not involved in the design and conduct of the study; collection, management, analysis or interpretation of the data; and preparation, review or approval of the manuscript. We thank Sonja Kiuru-Kuhlefelt, Anna Heino and Eija Vuori at the National Institute for Health and Welfare for their assistance in data collection.
Funding Information:
This research was supported by the Finnish Cultural Foundation, the Foundation for Paediatric Research, and the Kirsti and Tor Johansson’s Heart and Cancer Foundation as working grants for the corresponding author. The content is solely the responsibility of the authors and the funders were not involved in the design and conduct of the study; collection, management, analysis or interpretation of the data; and preparation, review or approval of the manuscript.
Publisher Copyright:
© 2018 Royal College of Obstetricians and Gynaecologists
PY - 2019/6
Y1 - 2019/6
N2 - Objective: To evaluate whether a nationwide prenatal anomaly screening programme improves detection rates of univentricular heart (UVH) and transposition of great arteries (TGA), and whether maternal risk factors for severe fetal heart disease affect prenatal detection. Design: Population-based cohort study. Setting: Nationwide data from Finnish registries 2004–14. Population: A total of 642 456 parturients and 3449 terminated pregnancies due to severe fetal anomaly. Methods: Prenatal detection rates were calculated in three time periods (prescreening, transition and screening phase). The effect of maternal risk factors (obesity, in vitro fertilisation, pregestational diabetes and smoking) was evaluated. Main outcome measures: Change in detection rates and impact of maternal risk factors on screening programme efficacy. Results: In total, 483 cases of UVH and 184 of TGA were detected. The prenatal detection rate of UVH increased from 50.4% to 82.8% and of TGA from 12.3% to 41.0% (P < 0.0001). Maternal risk factors did not affect prenatal detection rate, but detection rate differed substantially by region. Conclusions: A nationwide screening programme improved overall UVH and TGA detection rates, but regional differences were observed. Obesity or other maternal risk factors did not affect the screening programme efficacy. The establishment of structured guidelines and recommendations is essential when implementing the screening programme. In addition, a prospective screening register is highly recommended to ensure high quality of screening. Tweetable abstract: Implementation of a nationwide prenatal anomaly screening improved detection rates of UVH and TGA.
AB - Objective: To evaluate whether a nationwide prenatal anomaly screening programme improves detection rates of univentricular heart (UVH) and transposition of great arteries (TGA), and whether maternal risk factors for severe fetal heart disease affect prenatal detection. Design: Population-based cohort study. Setting: Nationwide data from Finnish registries 2004–14. Population: A total of 642 456 parturients and 3449 terminated pregnancies due to severe fetal anomaly. Methods: Prenatal detection rates were calculated in three time periods (prescreening, transition and screening phase). The effect of maternal risk factors (obesity, in vitro fertilisation, pregestational diabetes and smoking) was evaluated. Main outcome measures: Change in detection rates and impact of maternal risk factors on screening programme efficacy. Results: In total, 483 cases of UVH and 184 of TGA were detected. The prenatal detection rate of UVH increased from 50.4% to 82.8% and of TGA from 12.3% to 41.0% (P < 0.0001). Maternal risk factors did not affect prenatal detection rate, but detection rate differed substantially by region. Conclusions: A nationwide screening programme improved overall UVH and TGA detection rates, but regional differences were observed. Obesity or other maternal risk factors did not affect the screening programme efficacy. The establishment of structured guidelines and recommendations is essential when implementing the screening programme. In addition, a prospective screening register is highly recommended to ensure high quality of screening. Tweetable abstract: Implementation of a nationwide prenatal anomaly screening improved detection rates of UVH and TGA.
KW - Congenital heart disease
KW - prenatal diagnosis
KW - prenatal screening
KW - transposition of great arteries
KW - univentricular heart
UR - http://www.scopus.com/inward/record.url?scp=85060636011&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85060636011&partnerID=8YFLogxK
U2 - 10.1111/1471-0528.15589
DO - 10.1111/1471-0528.15589
M3 - Article
C2 - 30576052
AN - SCOPUS:85060636011
SN - 1470-0328
VL - 126
SP - 864
EP - 873
JO - BJOG: An International Journal of Obstetrics and Gynaecology
JF - BJOG: An International Journal of Obstetrics and Gynaecology
IS - 7
ER -